PHARMACEUTICS INTERNATIONAL, INC.

Profile

Company Names

PHARMACEUTICS INTERNATIONAL, INC.

Addresses

10819 GILROY ROAD, HUNT VALLEY, MD 21031

Phone Numbers

410-584-0001

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$206,479,419.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2024-06-03 
$11,249,998.00 
$11,249,998.00 
$0.00 
Equity 
16
2024-03-06 
$4,249,989.00 
$4,249,989.00 
$0.00 
Equity 
15
2023-06-16 
$6,000,000.00 
$12,000,000.00 
$6,000,000.00 
Equity 
14
2022-12-08 
$3,000,159.00 
$3,000,159.00 
$0.00 
Equity 
13
2022-09-23 
$9,007,812.00 
$9,007,812.00 
$0.00 
Equity 
12
2022-08-08 
$5,000,319.00 
$5,000,319.00 
$0.00 
Equity 
11
2022-06-27 
$5,000,319.00 
$5,000,319.00 
$0.00 
Equity 
10
2022-04-27 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
9
2022-03-02 
$5,000,319.00 
$5,000,319.00 
$0.00 
Equity 
8
2021-12-21 
$5,000,159.00 
$5,000,159.00 
$0.00 
Equity 
7
2021-10-14 
$5,000,159.00 
$5,000,159.00 
$0.00 
Equity 
6
2021-07-23 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
5
2021-05-21 
$3,000,159.00 
$3,000,159.00 
$0.00 
Equity 
4
2020-12-31 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
3
2018-10-22 
$5,971,142.00 
$15,000,000.00 
$9,028,858.00 
Equity 
2
2017-08-03 
$9,999,522.00 
$19,998,885.00 
$9,999,363.00 
Equity 
1
2016-08-31 
$107,999,363.00 
$107,999,363.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SANA 
E. 
ABIDI 
DIRECTOR
SANA 
I. 
ABIDI 
DIRECTOR
SHAHAB 
N. 
ABIDI 
DIRECTOR
SYED 
E. 
ABIDI 
EXECUTIVE OFFICER, DIRECTOR
SYED 
ABIDI, PH.D. 
DIRECTOR
SYED 
E. 
ABIDI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
BOGDA 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
I. 
BOGDA 
DIRECTOR
JILLIAN 
 
DETTINGER 
EXECUTIVE OFFICER
GERARD 
 
FLEURY 
EXECUTIVE OFFICER
JOHN 
 
FOWLER 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
I. 
FOWLER 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
E. 
GALE 
DIRECTOR
JAMES 
I. 
GALE 
DIRECTOR
JOHN 
 
GUTHRIE 
EXECUTIVE OFFICER
JOHN 
I. 
GUTHRIE 
EXECUTIVE OFFICER
JULIEN 
 
HECHT 
EXECUTIVE OFFICER
MARK 
 
KAVULICH 
DIRECTOR
JOSEPH 
 
KIELY 
EXECUTIVE OFFICER
KURT 
 
NIELSEN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
SHAHID 
 
RAZA 
DIRECTOR
DAVID 
I. 
SOLOMON 
DIRECTOR
GEORGE 
 
SVOKOS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-23 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-08-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TENEO SECURITIES LLC